ECS Botanics has launched a collection of promotional videos aimed at increasing sales among both domestic and overseas customers, with expectations for sustained revenue expansion in the upcoming quarter.
These videos showcase the company's processes, production methods, product advantages, and leadership, reaching both current clients and prospective partners.
The company expects to record approximately A$2 million in revenue for Q3 FY2022, representing a near 40% rise from the prior quarter and a 440% increase year-on-year.
The growth stems from strong performance in its dried flower and oil product lines, a trajectory the company anticipates will persist due to sustained market demand.
The company's medicinal cannabis business is expanding faster than its hemp food and wellness division and now dominates the revenue mix. A year prior, the hemp food and wellness segment accounted for the entire revenue base, while it now represents roughly 20% of quarterly sales.
This shift indicates the company's strategic move toward cannabis as its primary focus, delivering improved profitability and sustained shareholder returns.
Managing director Alex Keach said: “Our seed-to-GMP product business model for the B2B market continues to resonate with a range of customers, and this has allowed the company to unlock a number of… opportunities to underpin revenue growth.
Keach noted that the company is capitalizing on industry consolidation through the acquisition of additional business clients.
